Richard A. Young, Director at Syros Pharmaceuticals, Inc. (SYRS), sold 5,990 shares at $8.98 ($53K) on 2020-11-16, disclosed to the SEC on 2021-02-10.
Scheduled sale ($53k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.98 | 633 | $6K | 10.8% |
| 2 | $8.75 | 5,357 | $47K | 89.2% |
| Total | $8.77 avg | 5,990 | $53K | 100% |
| Filing → |
| OMGA | SELL | 2023-06-05 | $40K | — | Filing → |
| OMGA | SELL | 2023-05-03 | $40K | — | Filing → |
| OMGA | SELL | 2023-04-10 | $40K | — | Filing → |